Skip to main content
SpringerLink
Log in

Atherosclerosis

  • Chapter
Textbook of Angiology

  • 79 Accesses

Abstract

Atherosclerosis, a chronic disease of the large- and medium-caliber arteries, is currently considered inflammatory. This process, which begins in the intima, includes (1) focal lipid accumulation; (2) cell proliferation; and (3) production and deposition of connectival matrix, which leads to the formation of the fibrous-fatty lesion that evolves into an atheroma. In advanced atheromatous lesions, not only the intima but also the adjacent media and adventitia are involved.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Heart Association. The cholesterol facts: a summary of the evidence relating to dietary fats, blood cholesterol, and coronary artery disease. A joint statement by the AHA and the NHLBI. Circulation. 1990;81:1721–1733.

    Article  Google Scholar 

  2. Ang AH, Tachas G, Campbell JH, et al. Collagen synthesis by cultured rabbit aortic SMCs: alteration with phenotype. Biochem J. 1990;265:461–469.

    PubMed  CAS  Google Scholar 

  3. Austin MA, King MC, Vranizan KM, et al. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495–506.

    Article  PubMed  CAS  Google Scholar 

  4. Balkau B, Vray M, Eschwege E. Epidemiology of peripheral arterial disease. J Cardiovasc Pharmacol. 1994;23(suppl 3P):S8–S16.

    PubMed  Google Scholar 

  5. Berliner JA, Territo MC, Sevanian A, et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interaction. J Clin Invest. 1990;85:1260–1266.

    Article  PubMed  CAS  Google Scholar 

  6. Bondjers G, Glukhova M, Hasson GK, et al. Hypertension and atherosclerosis: cause and effect, or two effects with one unknown cause? Circulation. 1991;84(suppl 6):2–16.

    Google Scholar 

  7. Boulanger CM, Tanner FC, Bea ML, et al. Oxidized low density lipoproteins induce messenger RNA expression and release of endothelin from human and porcine endothelium. Circ Res. 1992;70:1191–1197.

    Article  PubMed  CAS  Google Scholar 

  8. BreslowJL. Transgenic mouse models of lipoprotein metabolism and atherosclerosis. Proc Natl Acad Sci U S A. 1993;90:8314–8318.

    Article  PubMed  CAS  Google Scholar 

  9. Brown RG, Zhao XQ, Sacco DE, et al. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 1993;87:1781–1791.

    Article  PubMed  CAS  Google Scholar 

  10. Burrig EL The endothelium of advanced arteriosclerotic plaques in humans. Arterioscler Thromb. 1991;11:1678–1689.

    Article  PubMed  CAS  Google Scholar 

  11. Chamley-Campbell JH, Campbell GR, Ross R. Phenotype-dependent response of cultured aortic smooth muscle toserum miogens. J Cell Biol. 1981;89:379–383.

    Article  PubMed  CAS  Google Scholar 

  12. Consensus Conference. Lowering blood cholesterol to prevent heart disease. JAMA. 1985;253:2080–2086.

    Article  Google Scholar 

  13. Couper JJ, Bates DJ, Cocciolone R, et al. Association of lipoprotein (a) with puberty in IDDM. Diabetes Care. 1993;16:869–873.

    Article  PubMed  CAS  Google Scholar 

  14. Criqui MH, Fronek A, Barret-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510–515.

    Article  PubMed  CAS  Google Scholar 

  15. Dahlen G, Guyton JR, Attar M, et al. Association of levels of lipoprotein Lp (a), plasma lipids, and other lipoproteins with coronary heart disease documented by angiography. Circulation. 1986;74:758–762.

    Article  PubMed  CAS  Google Scholar 

  16. Davies MJ. Pathology of arterial thrombosis. Br Med Bull. 1994;4:789–802.

    Google Scholar 

  17. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J. 1985;53:363–373.

    Article  PubMed  CAS  Google Scholar 

  18. De Palma RG. Patterns of peripheral atherosclerosis: implication for treatment. In: Shepherd JC, Morgan PD, Packard M, eds. Atherosclerosis: Developments, Complications, and Treatment. Amsterdam: Excerpta Medica; 1987:161–174.

    Google Scholar 

  19. DiCorleto PE, Soyombo AA. The role of endothelium in atherogenesis. Curr Opin Lipidol. 1993;4:364–372.

    Article  CAS  Google Scholar 

  20. Dzau VZ. Atherosclerosis and hypertension: mechanisms and interrelationship. J Cardiovasc Pharmacol. 1990;15(suppl 5):59–64.

    Google Scholar 

  21. Eggen DA, Solberg LA. Variation of atherosclerosis with age. Lab Invest. 1968;18:571–579.

    PubMed  CAS  Google Scholar 

  22. Feingold KR, Grunfeld C, Pang M, et al. LDL subclass phe-notypes and triglyceride metabolism in non insulin dependent diabetes. Arterioscler Thromb. 1992;12:1496–1502.

    Article  PubMed  CAS  Google Scholar 

  23. Fless GM, Rolich CA, Scanu AM. Heterogeneity of human plasma lipoprotein (a). J Biol Chem. 1984;258:11470–11474.

    Google Scholar 

  24. Frohlich JJ. Blood cholesterol is causally related to atherosclerosis. Card Res. 1994;28:574–578.

    Article  CAS  Google Scholar 

  25. Fuster V, Stein B, Ambrose JA, et al. Atherosclerotic plaque rupture and thrombosis. Circulation. 1990;82(suppl 2):47–59.

    Google Scholar 

  26. Giral P, Phitois-Merli I, Filitti V, et al. Risk factors and early extracoronary atherosclerotic plaques detected by three sites ultrasound imaging in hypercholesterolemic men. Arch Intern Med. 1991;151:950–956.

    Article  PubMed  CAS  Google Scholar 

  27. GoIdstein JL, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York, NY: McGraw-Hill; 1989:1215–1250.

    Google Scholar 

  28. Grant PJ, Kruithof EKO, Felley CD, et al. Short-term infusion of insulin, triacylglycerol, and glucose do not cause acute increases in plasminogen activator inhibitor-1 concentration in man. Clin Sci. 1990;79:513–516.

    PubMed  CAS  Google Scholar 

  29. Guyton JR. The arterial wall and the atherosclerotic lesion. Curr Opin Lipidol. 1994;5:376–381.

    Article  PubMed  CAS  Google Scholar 

  30. Hamsten A, De Faire U, Waldius G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987;2:3–9.

    Article  PubMed  CAS  Google Scholar 

  31. Hamsten A, Wiman B, De Faire U, et al. Increased plasma levels of rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med. 1985;313:1557–1563.

    Article  PubMed  CAS  Google Scholar 

  32. Havel RJ, Rapaport E. Management of primary hyperlip-idemia. Drug Ther. 1995;332:1491–1498.

    CAS  Google Scholar 

  33. Heiss G, Sharrett AR, Barnes R, et al. Carotid atherosclerosis measured by B mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 1991;3:250–256.

    Google Scholar 

  34. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by the receptor for acetylated low density lipoproteins. Proc Natl Acad Sci USA. 1981;78:6499–6503.

    Article  PubMed  CAS  Google Scholar 

  35. Hermanson B, Gilbert S, Omenn MD, et al. Beneficial six year outcome of smoking cessation in older men and women with coronary artery disease. N Engl J Med. 1988;319:1365–1369.

    Article  PubMed  CAS  Google Scholar 

  36. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 1987;28:613–628.

    PubMed  CAS  Google Scholar 

  37. Howard G, Burke GL, Szklo M, et al. Active and passive smoking are associated with increased carotid wall thickness: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1994;154:1277–1282.

    Article  PubMed  CAS  Google Scholar 

  38. Hypertension Detection and Follow Up Group. The effect of treatment on mortality in “mild” hypertension. N Engl J Med. 1982;307:976–980.

    Article  Google Scholar 

  39. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. JAMA. 1979;242:2562–2567.

    Article  Google Scholar 

  40. Kannel WB, Castelli WP, Gordon T. Serum cholesterol, lipoproteins, and risk of coronary heart disease: the Framingham Study. Ann Intern Med. 1971;74:1–9.

    PubMed  CAS  Google Scholar 

  41. Keys A. Coronary heart disease in seven countries. Circulation. 1970;41(suppl):211–218.

    Google Scholar 

  42. Krauss RM. Heterogeneity of plasma low density lipoproteins and atherosclerosis risk. Curr Opin Lipidol. 1994;5:339–349.

    Article  PubMed  CAS  Google Scholar 

  43. Kume N, Cybulski MI, Gimbrone MA Jr. Lysophosphaty-dylcoline, a component of atherogenic lipoproteins, induces mononuclear leucocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138–1144.

    Article  PubMed  CAS  Google Scholar 

  44. La Rosa JC, Cleeman JI. Cholesterol lowering as a treatment for established coronary heart disease. Circulation. 1992;85:1229–1235.

    Article  Google Scholar 

  45. Lakier JB. Smoking and cardiovascular disease. Am J Med. 1992;93(suppl IA):8–12.

    Article  Google Scholar 

  46. Lefer AM, Ma X. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb. 1993;13:771–776.

    Article  PubMed  CAS  Google Scholar 

  47. Libby P. Inflammatory and immune mechanisms in atherogenesis. J Immunol. 1990;144:2343–2350.

    Google Scholar 

  48. Libby P, Clinton SK. The role of macrophages in atherogenesis. Curr Opin Lipidol. 1993;4:355–363.

    Article  CAS  Google Scholar 

  49. Lithell H. Pathogenesis and prevalence of atherosclerosis in hypertensive patients. Am J Hypertens. 1994;7:2–6.

    Google Scholar 

  50. Marmot MG, Syme SL, Kagan A, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: prevalence of coronary and hypertensive heart disease and associated risk factors. Am J Epidemiol. 1975;102:514–519.

    PubMed  CAS  Google Scholar 

  51. Maser RE, Wolfson SK, Ellis D, et al. Cardiovascular disease and arterial calcification in insulin dependent diabetes mellitus: interrelations and risk factor profiles. Arterioscler Thromb. 1991;11:958–996.

    Article  PubMed  CAS  Google Scholar 

  52. McGill HC Jr. Potential mechanism for the augmentation of atherosclerosis and atherosclerotic disease by cigarette smoking. Prev Med. 1979;8:390–393.

    Article  PubMed  CAS  Google Scholar 

  53. Miles LA, Plow EF. Lp(a): an interloper in the fibrinolytic system. Thromb Haemost. 1990;63:331–334.

    PubMed  CAS  Google Scholar 

  54. Mizutani M, Okuda Y, Yamaoka T, et al. High glucose and hyperosmolarity increase platelet derived growth factor mRNA levels in cultured human vascular endothelial cells. Biochem Biophys Res Commun. 1992;187:664–669.

    Article  PubMed  CAS  Google Scholar 

  55. National Center for Health Statistics. Advance Report of Final Mortality Statistics, 1986. Hyattsville, Md: Public Health Service; 1988. DHHS publication PHS 88-1220.

    Google Scholar 

  56. Nishina PM, Johnson JP, Naggert JK, et al. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc Natl Acad Sci U S A. 1992;89:708–712.

    Article  PubMed  CAS  Google Scholar 

  57. Nordestgaard BG, Tybjaerg-Hansen A, Lewis B. Influx in vivo of low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits: role of plasma concentration, extent of aortic lesion, and lipoprotein particle size as determinants. Arterioscler Thromb. 1992;12:6–18.

    Article  PubMed  CAS  Google Scholar 

  58. P-Day Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentration and smoking. JAMA. 1990;264:3018–3024.

    Article  Google Scholar 

  59. Parthasarathy S, Steinberg D. Cell-induced oxidation of LDL. Curr Opin Lipidol. 1992;3:313–317.

    Article  CAS  Google Scholar 

  60. Reaven GM. Banting lecture: role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607.

    Article  PubMed  CAS  Google Scholar 

  61. Reaven GM, Chen YDI, Jeppesen J, et al. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest. 1993;92:141–146.

    Article  PubMed  CAS  Google Scholar 

  62. Reidy AM, Bowyer DE. Control of arterial smooth muscle cell proliferation. Curr Opin Lipidol. 1993;4:349–354.

    Article  CAS  Google Scholar 

  63. Resnick N, Collins T, Atkinson W, et al. Platelet derived growth factor B chain promoter contains a as-acting fluid shear-stress-responsive element. Proc Natl Acad Sci U S A. 1993;90:4591–4595.

    Article  PubMed  CAS  Google Scholar 

  64. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488–499.

    Article  PubMed  CAS  Google Scholar 

  65. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809.

    Article  PubMed  CAS  Google Scholar 

  66. Rossow JE, Lewis B, Rifkind BM. The value of lowering cholesterol after myocardial infarction. N Engl J Med. 1990;323:1113–1119.

    Google Scholar 

  67. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 1992;339:883–887.

    Article  PubMed  CAS  Google Scholar 

  68. Schettler FG, Wollenweber J. Clinical aspect. In: Schettler FG and Boyd A, eds. Atherosclerosis. Amsterdam: Elsevier; 1969:633–672.

    Google Scholar 

  69. Schwartz CJ, Kelley JL, Nerem RM, et al. Pathophysiology of the atherogenic process. Am J Cardiol. 1989;64:23G–30G.

    Article  PubMed  CAS  Google Scholar 

  70. Stamler J, Wentworth MPH, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356222 primary screens of Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256:2823–2830.

    Article  PubMed  CAS  Google Scholar 

  71. Stary HC. Evolution and progression of atherosclerosis: implication for treatment. In: Shepherd JC, Morgan PD, Packard M, eds. Atherosclerosis: Developments, Complications, and Treatment. Amsterdam: Excerpta Medica; 1989:161–174.

    Google Scholar 

  72. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis. 1989;9(suppl 1):19–32.

    Google Scholar 

  73. Stary HC, Chadler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462–2478.

    Article  PubMed  CAS  Google Scholar 

  74. Steinberg D, Workshop Participants. Antioxidants in the prevention of human atherosclerosis: summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5–6, Bethesda, Maryland. Circulation. 1992;85:2337–2344.

    Article  PubMed  CAS  Google Scholar 

  75. Steinbrecher UP, Witztum JL, Kesaniemi YA, et al. Comparison of glucosylated LDL with methylated or cyclo-hexanedione-treated LDL in the measurement of receptorindependent LDL catabolism. J Clin Invest. 1983;7:960–964.

    Article  Google Scholar 

  76. Stender S, Hjelms E. In-vivo influx of free and esterified plasma cholesterol into human aortic tissue without atherosclerotic lesions. J Clin Invest. 1984;74:1871–1881.

    Article  PubMed  CAS  Google Scholar 

  77. Strandness DE, Didisheim P, Clowes AW, et al., eds. Vascular Diseases: Current Research and Clinical Application. Orlando, Fla: Grune & Stratton; 1987.

    Google Scholar 

  78. Strong JP, McGill HC Jr. The pediatric aspects of atherosclerosis. J Atheroscl Res. 1969;32:251–265.

    Article  Google Scholar 

  79. Thorn TJ. Stroke mortality trends: an international perspective. Ann Epidemiol. 1993;5:509–518.

    Google Scholar 

  80. Tribble DL, Holl LG, Wood PG, et al. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 1992;93:189–199.

    Article  PubMed  CAS  Google Scholar 

  81. Urakami K, Mura T, Takahashi K. Lp(a) lipoprotein in cerebrovascular disease and dementia. Jpn J Psychiatry Neurol. 1987;41:743–746.

    PubMed  CAS  Google Scholar 

  82. US Department of Health and Human Services. Current Estimates from the National Health Interview Survey, United States, 1985. Hyattsville, Md: National Center for Health Statistics; 1986.

    Google Scholar 

  83. Vague JI, Vague PH, Alessi MC, et al. Relationship between plasma insulin, triglyceride, body mass index, and plas-minogen activator inhibitor. Diabete Metab. 1987;13:331–336.

    PubMed  Google Scholar 

  84. Widmar LK, Greensher A, Kannel WB. Occlusion of peripheral arteries: a study of 6400 working subjects. Circulation. 1964;30:836–842.

    Article  Google Scholar 

  85. Wissler RW, Vesselinovitch D. Can atherosclerotic plaquesregress? Anatomic and biochemical evidence from non human animal models. Am J Cardiol. 1990;65:33F–40F.

    Article  PubMed  CAS  Google Scholar 

  86. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:21785–21792.

    Article  Google Scholar 

Download references

Authors
  1. Graziana Lupattelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elmo Mannarino
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. International College of Angiology, Inc., USA

    John B. Chang MD, FACS, FICA (Chairman, Board of Directors, Director) (Chairman, Board of Directors, Director)

  2. Long Island Vascular Center, 1050, Northern Boulevard, Roslyn, NY, 11576, USA

    John B. Chang MD, FACS, FICA (Chairman, Board of Directors, Director) (Chairman, Board of Directors, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lupattelli, G., Mannarino, E. (2000). Atherosclerosis. In: Chang, J.B. (eds) Textbook of Angiology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1190-7_36

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1190-7_36

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7039-3

  • Online ISBN: 978-1-4612-1190-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation